The next board meeting for Outlook Therapeutics Inc is on 15 May 2026 for the purpose of Outlook Therapeutics Inc Second Quarter Earnings Results for 2026See details
Outlook Therapeutics Inc - OTLK - stock price prediction, stock price target, analyst ratings from 3 analysts
Outlook Therapeutics Inc has a share price target of US$ 4, revenue growth forecast of 1405.0%, and profit growth estimate of 24.3% for FY26, based on top 3 analyst calls.